• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

p53 信号通路相关因子 GADD45B 和 SERPINE1 在胃癌发生发展中的关键作用。

Key Roles of p53 Signaling Pathway-Related Factors GADD45B and SERPINE1 in the Occurrence and Development of Gastric Cancer.

机构信息

Department of Gastrointestinal Surgery, Shaoxing People's Hospital, Shaoxing 312000, China.

Department of Radiology, Shaoxing People's Hospital, Shaoxing 312000, China.

出版信息

Mediators Inflamm. 2023 Aug 24;2023:6368893. doi: 10.1155/2023/6368893. eCollection 2023.

DOI:10.1155/2023/6368893
PMID:37662480
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10471451/
Abstract

p53 can function as an independent and unfavorable prognosis biomarker in cancer patients. We tried to identify the key factors of the p53 signaling pathway involved in gastric cancer (GC) occurrence and development based on the genotype-tissue expression (GTEx) and the Cancer Genome Atlas (TCGA) screening. We downloaded gene expression data and clinical data of GC included in the GTEx and TCGA databases, followed by differential analysis. Then, the key factors in the p53 signaling pathway were identified, followed by an analysis of the correlation between key factors and the prognosis of GC patients. Human GC cell lines were selected for cell experiments to verify the effects of key prognostic factors on the proliferation, migration, invasion, and apoptosis of GC cells. We found 4,944 significantly differentially expressed genes (DEGs), of which 2,465 were upregulated and 2,479 downregulated in GC. Then, 27 DEGs were found to be involved in the p53 signaling pathway. GADD45B and SERPINE1 genes were prognostic high-risk genes. The regression coefficients of GADD45B and SERPINE1 were positive. GADD45B was poorly expressed, while SERPINE1 was highly expressed in GC tissues, highlighting their prognostic role in GC. The cell experiments confirmed that overexpression of GADD45B or silencing of SERPINE1 could inhibit the proliferation, migration, and invasion and augment the apoptosis of GC cells. Collectively, the p53 signaling pathway-related factors GADD45B and SERPINE1 may be key genes that participate in the development of GC.

摘要

p53 可作为癌症患者独立的不良预后生物标志物。我们试图根据基因型组织表达 (GTEx) 和癌症基因组图谱 (TCGA) 筛选,确定参与胃癌 (GC) 发生和发展的 p53 信号通路的关键因素。我们下载了 GTEx 和 TCGA 数据库中包含的 GC 的基因表达数据和临床数据,随后进行了差异分析。然后,确定了 p53 信号通路中的关键因素,并分析了关键因素与 GC 患者预后的相关性。选择人类 GC 细胞系进行细胞实验,以验证关键预后因素对 GC 细胞增殖、迁移、侵袭和凋亡的影响。我们发现 4944 个显著差异表达基因 (DEGs),其中 GC 中 2465 个上调,2479 个下调。然后,发现 27 个 DEGs 参与了 p53 信号通路。GADD45B 和 SERPINE1 基因是预后高危基因。GADD45B 和 SERPINE1 的回归系数为正。GADD45B 在 GC 组织中表达水平较低,而 SERPINE1 表达水平较高,这突出了它们在 GC 中的预后作用。细胞实验证实,过表达 GADD45B 或沉默 SERPINE1 可抑制 GC 细胞的增殖、迁移和侵袭,并促进其凋亡。总之,p53 信号通路相关因子 GADD45B 和 SERPINE1 可能是参与 GC 发展的关键基因。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e044/10471451/d8b802b75e71/MI2023-6368893.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e044/10471451/b93ca30e6c41/MI2023-6368893.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e044/10471451/e616fd544087/MI2023-6368893.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e044/10471451/f794fa4b39f6/MI2023-6368893.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e044/10471451/890b1cf150a2/MI2023-6368893.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e044/10471451/de40d60bb5a8/MI2023-6368893.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e044/10471451/af758d2b45a8/MI2023-6368893.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e044/10471451/b4ff5271066e/MI2023-6368893.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e044/10471451/9c7cd3c1961d/MI2023-6368893.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e044/10471451/d8b802b75e71/MI2023-6368893.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e044/10471451/b93ca30e6c41/MI2023-6368893.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e044/10471451/e616fd544087/MI2023-6368893.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e044/10471451/f794fa4b39f6/MI2023-6368893.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e044/10471451/890b1cf150a2/MI2023-6368893.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e044/10471451/de40d60bb5a8/MI2023-6368893.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e044/10471451/af758d2b45a8/MI2023-6368893.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e044/10471451/b4ff5271066e/MI2023-6368893.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e044/10471451/9c7cd3c1961d/MI2023-6368893.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e044/10471451/d8b802b75e71/MI2023-6368893.009.jpg

相似文献

1
Key Roles of p53 Signaling Pathway-Related Factors GADD45B and SERPINE1 in the Occurrence and Development of Gastric Cancer.p53 信号通路相关因子 GADD45B 和 SERPINE1 在胃癌发生发展中的关键作用。
Mediators Inflamm. 2023 Aug 24;2023:6368893. doi: 10.1155/2023/6368893. eCollection 2023.
2
GADD45B regulates the carcinogenesis process of chronic atrophic gastritis and the metabolic pathways of gastric cancer.GADD45B 调控慢性萎缩性胃炎的癌变过程和胃癌的代谢途径。
Front Endocrinol (Lausanne). 2023 Aug 7;14:1224832. doi: 10.3389/fendo.2023.1224832. eCollection 2023.
3
Cuproptosis-related gene SERPINE1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.铜死亡相关基因 SERPINE1 是胃癌的预后生物标志物,并与免疫浸润相关。
J Cancer Res Clin Oncol. 2023 Sep;149(12):10851-10865. doi: 10.1007/s00432-023-04900-1. Epub 2023 Jun 15.
4
Pan-cancer analysis of SERPINE1 with a concentration on immune therapeutic and prognostic in gastric cancer.SERPINE1在胃癌中的泛癌分析:聚焦免疫治疗与预后
J Cell Mol Med. 2024 Aug;28(15):e18579. doi: 10.1111/jcmm.18579.
5
Identification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis.通过综合分析鉴定与胃癌预后相关的关键基因。
Biosci Rep. 2021 Apr 30;41(4). doi: 10.1042/BSR20203676.
6
MircoRNA-1275 promotes proliferation, invasion and migration of glioma cells via SERPINE1.微小 RNA-1275 通过丝氨酸蛋白酶抑制剂 1 促进神经胶质瘤细胞的增殖、侵袭和迁移。
J Cell Mol Med. 2018 Oct;22(10):4963-4974. doi: 10.1111/jcmm.13760. Epub 2018 Jul 19.
7
SERPINE1 Overexpression Promotes Malignant Progression and Poor Prognosis of Gastric Cancer.丝氨酸蛋白酶抑制剂E1过表达促进胃癌的恶性进展和不良预后。
J Oncol. 2022 Jan 29;2022:2647825. doi: 10.1155/2022/2647825. eCollection 2022.
8
Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer.加权相关网络分析确定了与胃癌进展和预后相关的纤连蛋白1(FN1)、I型胶原蛋白α1链(COL1A1)和纤溶酶原激活物抑制剂1(SERPINE1)。
Cancer Biomark. 2021;31(1):59-75. doi: 10.3233/CBM-200594.
9
MicroRNA-18a modulates P53 expression by targeting IRF2 in gastric cancer patients.微小RNA-18a通过靶向胃癌患者中的干扰素调节因子2来调控P53表达。
J Gastroenterol Hepatol. 2016 Jan;31(1):155-63. doi: 10.1111/jgh.13041.
10
Intracellular matrix Gla protein promotes tumor progression by activating JAK2/STAT5 signaling in gastric cancer.细胞外基质 Gla 蛋白通过激活胃癌中的 JAK2/STAT5 信号通路促进肿瘤进展。
Mol Oncol. 2020 May;14(5):1045-1058. doi: 10.1002/1878-0261.12652. Epub 2020 Mar 16.

引用本文的文献

1
Shanling Jiangzhi Tea treats hyperuricemia by inhibition of COMT/MAOA signaling pathway and p53/SERPINE1/NLRP3 signaling pathway.山灵降旨茶通过抑制儿茶酚-O-甲基转移酶/单胺氧化酶信号通路和p53/丝氨酸蛋白酶抑制剂1/NLRP3信号通路来治疗高尿酸血症。
Front Endocrinol (Lausanne). 2025 Jul 11;16:1623111. doi: 10.3389/fendo.2025.1623111. eCollection 2025.
2
G Protein-coupled Estrogen Receptor 1 (GPER1) Regulates Expression of /PAI-1 and Inhibits Tumorigenic Potential of Cervical Squamous Cell Carcinoma Cells .G蛋白偶联雌激素受体1(GPER1)调节纤溶酶原激活物抑制因子-1(PAI-1)的表达并抑制宫颈鳞状细胞癌细胞的致瘤潜能。
Cancer Genomics Proteomics. 2025 Jan-Feb;22(1):13-23. doi: 10.21873/cgp.20482.
3

本文引用的文献

1
Identification of a seven-cell cycle signature predicting overall survival for gastric cancer.鉴定出一个七细胞周期特征可预测胃癌的总生存期。
Aging (Albany NY). 2022 May 10;14(9):3989-3999. doi: 10.18632/aging.204060.
2
Comprehensive analysis reveals , , and as the novel prognostic markers in gastric cancer.综合分析显示, 、 、 和 为胃癌新的预后标志物。 (注:原文中“ , , and ”部分内容缺失,请补充完整后再进行准确翻译)
Transl Cancer Res. 2020 Jul;9(7):4093-4110. doi: 10.21037/tcr-20-211.
3
Targeting mutant p53 for cancer therapy: direct and indirect strategies.
Circadian rhythm genes contribute to the prognosis prediction and potential therapeutic target in gastric cancer.
昼夜节律基因与胃癌的预后预测和潜在治疗靶点有关。
Sci Rep. 2024 Oct 25;14(1):25426. doi: 10.1038/s41598-024-76565-w.
4
Sepsis induces the cardiomyocyte apoptosis and cardiac dysfunction through activation of YAP1/Serpine1/caspase-3 pathway.脓毒症通过激活YAP1/丝氨酸蛋白酶抑制剂1/半胱天冬酶-3信号通路诱导心肌细胞凋亡和心脏功能障碍。
Open Med (Wars). 2024 Sep 17;19(1):20241018. doi: 10.1515/med-2024-1018. eCollection 2024.
针对癌症治疗的突变型 p53 靶点:直接和间接策略。
J Hematol Oncol. 2021 Sep 28;14(1):157. doi: 10.1186/s13045-021-01169-0.
4
Molecular Alterations in Gastric Preneoplastic Lesions and Early Gastric Cancer.胃前病变和早期胃癌的分子改变。
Int J Mol Sci. 2021 Jun 22;22(13):6652. doi: 10.3390/ijms22136652.
5
Establishment of a prognostic model of four genes in gastric cancer based on multiple data sets.基于多个数据集建立胃癌的四个基因预后模型。
Cancer Med. 2021 May;10(10):3309-3322. doi: 10.1002/cam4.3654. Epub 2021 May 2.
6
Ring finger 20/ring finger 40/WW domain-containing adaptor with coiled-coil complex interacts with p53 to regulate gene transcription in DNA damage response.含卷曲螺旋结构域的无名指 20/无名指 40/WW 结构域衔接蛋白复合物与 p53 相互作用,以调控 DNA 损伤反应中的基因转录。
Oncol Lett. 2021 Jun;21(6):436. doi: 10.3892/ol.2021.12697. Epub 2021 Apr 1.
7
MDM4 as a Prognostic Factor for Patients With Gastric Cancer With Low Expression of p53.MDM4 作为低表达 p53 的胃癌患者的预后因素。
Anticancer Res. 2021 Mar;41(3):1475-1483. doi: 10.21873/anticanres.14906.
8
Hedgehog signaling in gastrointestinal carcinogenesis and the gastrointestinal tumor microenvironment.刺猬信号通路在胃肠道肿瘤发生及胃肠道肿瘤微环境中的作用
Acta Pharm Sin B. 2021 Mar;11(3):609-620. doi: 10.1016/j.apsb.2020.10.022. Epub 2020 Oct 29.
9
Pan-Cancer Analysis of NOS3 Identifies Its Expression and Clinical Relevance in Gastric Cancer.一氧化氮合酶3(NOS3)的泛癌分析确定了其在胃癌中的表达及临床相关性。
Front Oncol. 2021 Mar 4;11:592761. doi: 10.3389/fonc.2021.592761. eCollection 2021.
10
Gastric cancer.胃癌。
Lancet. 2020 Aug 29;396(10251):635-648. doi: 10.1016/S0140-6736(20)31288-5.